Injectable Influenza Vaccine
Closed Pre-Solicitation Posted
This opportunity was awarded. See its 2 award notices in the notice history.
- Solicitation number
- SPE2DP22R0004
- Agency
- Medical Supply Chain Troop Support, Department of Defense
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Place of performance
- United States
Notice details come from SAM.gov. Updated .
About this opportunity
The Defense Logistics Agency Troop Support is seeking proposals for the supply of approximately 3.39 million doses of injectable influenza vaccine for the 2023-2024 flu season. The vaccine must be FDA-approved for use in individuals ages 65 and over, ages 18 and older, ages 3 and older, and include a pediatric formulation for ages 6 months to 35 months. Proposals are due by August 17, 2022. Successful offerors must have FDA approval for their vaccine and an ACIP recommendation. Delivery of 40% of the doses is required by August 11, 2023, with additional staggered deliveries required through September 22, 2023.
No set-aside designation was used. The primary NAICS code is 325412 and PSC code is 6505. The contract will be an indefinite delivery, indefinite quantity agreement with a minimum quantity of 75% and maximum of 150% of the estimated 3.39 million doses. All doses must be delivered to the Defense Depot in New Cumberland, Pennsylvania.
Notice text
The Defense Logistics Agency Troop Support is soliciting for the supply of Injectable Influenza Vaccine for the 2023-2024 flu season. Approximately 3.39 million doses are included in this requirement. (Quantities may increase or decrease pending receipt of final Service requirements.) The vaccines shall be in the following presentations: multi-dose vials and prefilled syringes. The vaccine shall be FDA-approved for the following age categories: for immunizing individuals 65 years and older, for immunizing individuals 18 years and older, for immunizing individuals 3 years and older, and a 10-pack prefilled syringes for immunizing 6 months to 35 months (pediatric group).
The formula for the 2023-2024 season shall be determined by the FDA’s Vaccines and Related Biological Products Advisory Committee. Other specification data is included in the solicitation. Successful contractor must have FDA Approval and the vaccine must be ACIP recommended. National Stock Numbers shall be established at time of award.
An indefinite quantity contract is proposed. The quantity indicated is an annual estimate only. The guaranteed minimum will be 75% of the annual estimate, and a contract maximum will be established at 150% of the annual estimate.
All quantities shall be delivered to the Defense Depot New Cumberland, PA. The contractor shall be capable of delivering 40% of the requirement by August 11, 2023, 25% by August 25, 2023, 25% by September 8, 2023 and the residual 10% by September 22, 2023. This delivery schedule is the preferred delivery schedule. Other delivery schedules will be considered.
Notice history
| Notice | Type | Posted |
|---|---|---|
| Injectable Influenza Vaccine | Award Notice | |
| Injectable Influenza Vaccine | Award Notice | |
| Injectable Influenza Vaccine | Solicitation | |
| Injectable Influenza Vaccine | Pre-Solicitation |
On GovTribe
Work this opportunity on GovTribe
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity